Following years of progressive deterioration of this chronic disease, patients see dramatic improvement in their quality of life
BONITA SPRINGS, Fla.--(BUSINESS WIRE)-- Angelo DiStefano, 50, has struggled with the symptoms of cystic fibrosis his entire life. He was confined to a wheelchair and every breath was a challenge. DiStefano and his wife spent years researching a variety of treatments that could improve his condition. They discovered Zannos G. Grekos, MD, MAAC, FACC, chief medical officer of Regenocyte and a leading pioneer in the field of adult stem cell therapy, and worked with him to determine a new course of treatment.
Cystic fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide). A defective gene and its protein product cause the body to produce unusually thick, sticky mucus that clogs the lungs and leads to life-threatening lung infections; and obstructs the pancreas and stops natural enzymes from helping the body break down and absorb food.1
With help from The Alliance for the Advancement of Adult Stem Cell Therapy and Research, DiStefano received his first Regenocyte adult stem cell treatment on May 4, 2011 in the Dominican Republic. Since only adult stem cells are used, the political, ethical and medical issues surrounding embryonic stem cells are avoided and there is no risk of rejection from the patient.
In only a few months, his pulmonary function test (PFT) results show an increase in FEV1 from 18% to 32%, he is walking on his own, and he is able to leave the house to enjoy time with his wife.
“He has surpassed all odds. He is ecstatic to be out of the wheelchair and is grateful to have hope again. I am overwhelmed by the improvement in his quality of life. I have my husband back,” said DiStefano’s wife, Gari.
Kelly Drouin, Director of The Alliance said, “Providing support to patients like Angelo is one of the cornerstones of our mission. The extraordinary results we’ve seen with him and numerous other patients confirms the necessity of ensuring this life-improving treatment is available to everyone, regardless of their ability to pay.”
Another Regenocyte patient, Carrie Salback, 40, was diagnosed with cystic fibrosis as a child. Salback had gotten so bad she couldn’t climb a flight of stairs without stopping several times to catch her breath.
Salback’s daughter read a story about adult stem cells in Popular Science magazine that featured a pulmonary patient treated by Dr. Grekos. In an attempt to help her mother, Salback’s daughter Ashley reached out to Regenocyte to determine if adult stem cells were an option for treating cystic fibrosis.
On February 24th, 2011 Salback underwent Regenocyte adult stem cell therapy to treat her condition. Since the procedure she has seen a vast improvement in her lifestyle, including getting up early to go walking and skating. She too had an improvement in her PFTs, but more importantly has had no infections or hospitalizations since treatment.
“I am encouraged by the progress we’re making with treating cystic fibrosis using a patient’s own stem cells. We are finding an improvement in patients functional capacity and pulmonary testing, as well as an across the board reduction in infections and hospitalizations,” said Dr. Grekos. “We have seen remarkable results with serious heart, vascular, and pulmonary diseases, and these results are showing promise for successfully treating many other conditions.”
Dr. Grekos and the Regenocyte medical team continue to research the impact of adult stem cell therapy on cystic fibrosis and other chronic lung conditions. He periodically conducts seminars to educate the public about adult stem cell therapy. For more information, call 1-866-216-5710 or visit www.regenocyte.com.
ABOUT THE ALLIANCE FOR THE ADVANCEMENT OF ADULT STEM CELL THERAPY AND RESEARCH
The Alliance for the Advancement of Adult Stem Cell Therapy and Research is a non-profit organization dedicated to promoting the use of adult stem cells in the research and treatment of life-altering diseases. This alliance also strives to ensure treatment for those who qualify and could not otherwise afford to receive it. To become a supporting member, please visit www.thestemcellalliance.org or call (239) 498-9187.
ABOUT REGENOCYTE THERAPEUTIC
Working in collaboration with major international treatment and research centers, Dr. Zannos Grekos has developed many of the protocols used for adult stem cell therapy throughout the world. Regenocyte Therapeutic treats congestive heart failure, cardiomyopathy, peripheral artery disease, coronary artery disease, ischemic heart disease and pulmonary disease. For more information, visit www.regenocyte.com.
1 – Cystic Fibrosis Foundation. www.cff.org
The Alliance for the Advancement of Adult Stem Cell Therapy and Research
Greg Finley, 239-495-2252
Director of Communications & Education
KEYWORDS: United States North America Florida
INDUSTRY KEYWORDS: Health Biotechnology Clinical Trials Genetics Other Health Research Science